...
机译:VEGFR2和β
Division of Physiology Pharmacology &
Neuroscience School of Life Sciences University of Nottingham;
Division of Physiology Pharmacology &
Neuroscience School of Life Sciences University of Nottingham;
Division of Physiology Pharmacology &
Neuroscience School of Life Sciences University of Nottingham;
Division of Physiology Pharmacology &
Neuroscience School of Life Sciences University of Nottingham;
Division of Physiology Pharmacology &
Neuroscience School of Life Sciences University of Nottingham;
Promega Corporation;
Wolfson Centre for Stem Cells Tissue Engineering &
Modelling (STEM) Centre for Biomolecular Sciences University of Nottingham;
Harry Perkins Institute of Medical Research and Centre for Medical Research The University of Western Australia Nedlands;
Promega Corporation;
Promega Corporation;
Promega Corporation;
Drug Discovery Biology Monash Institute of Pharmaceutical Sciences Monash University Parkville;
Division of Physiology Pharmacology &
Neuroscience School of Life Sciences University of Nottingham;
Division of Physiology Pharmacology &
Neuroscience School of Life Sciences University of Nottingham;
VEGFR2; β2-adrenoceptors; BRET; NanoBRET; CRISPR/Cas9; β-arrestin; receptor oligomerisation; infantile haemangioma;
机译:VEGFR2和β
机译:来自RHCL的支持RH复合物的结构阐明(PPH
机译:抑制配体臂水解和羧酸盐配位的μ
机译:后氧化退火对H
机译:formin INF2的剪接变异特异性细胞和生化功能
机译:反向Formin 2的纳米结构自组装(INF2)和F-Actin–INF2复合物的原子揭示力显微镜
机译:新型超长效β